Menu Search
Equities

Abingdon Health PLC

ABDXF:PKC

Abingdon Health PLC

Actions
  • Price (USD)0.07
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Aug 19 2022.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is engaged in offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. It focuses on supporting the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas, such as infectious disease, clinical testing including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. It also specializes in meeting compliance requirements in the international IVD and medical device markets.

  • Revenue in GBP (TTM)5.34m
  • Net income in GBP-2.24m
  • Incorporated2008
  • Employees82.00
  • Location
    Abingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
  • Phone+44 190 440 6050
  • Fax+44 190 446 2122
  • Websitehttps://www.abingdonhealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ABDX:LSE since
announced		Transaction
value
Compliance Solutions Group LLCDeal completed24 Jul 202424 Jul 2024Deal completed-13.49%4.12m
Data delayed at least 20 minutes, as of Sep 20 2024 15:47 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.